Perrigo Company plc (PRGO)
NYSE: PRGO · Real-Time Price · USD
23.66
+0.59 (2.56%)
At close: Aug 13, 2025, 4:00 PM
23.74
+0.08 (0.34%)
Pre-market: Aug 14, 2025, 8:00 AM EDT
Perrigo Company Revenue
Perrigo Company had revenue of $1.06B in the quarter ending June 28, 2025, a decrease of -0.86%. This brings the company's revenue in the last twelve months to $4.33B, down -2.31% year-over-year. In the year 2024, Perrigo Company had annual revenue of $4.37B, down -6.06%.
Revenue (ttm)
$4.33B
Revenue Growth
-2.31%
P/S Ratio
0.75
Revenue / Employee
$516,303
Employees
8,379
Market Cap
3.26B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 4.37B | -282.20M | -6.06% |
Dec 31, 2023 | 4.66B | 204.00M | 4.58% |
Dec 31, 2022 | 4.45B | 312.90M | 7.56% |
Dec 31, 2021 | 4.14B | 50.50M | 1.24% |
Dec 31, 2020 | 4.09B | 218.30M | 5.64% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
PRGO News
- 7 days ago - Perrigo Company plc (PRGO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 8 days ago - Perrigo Reports Second Quarter 2025 Financial Results From Continuing Operations - PRNewsWire
- 14 days ago - Perrigo Announces Quarterly Dividend - PRNewsWire
- 16 days ago - Perrigo to Present at the Canaccord Genuity 45th Annual Growth Conference - PRNewsWire
- 22 days ago - Perrigo to Release Second Quarter 2025 Financial Results on August 6, 2025 - PRNewsWire
- 4 weeks ago - Perrigo Announces Agreement to Divest Dermacosmetics Business for up to €327 Million - PRNewsWire
- 6 weeks ago - Perrigo Announces Strategic Organizational Update to Drive Sustainable Growth and Performance - PRNewsWire
- 6 weeks ago - Good Start® | Dr. Brown's™ Launches 30-Day "Gentle Baby Formula Giveaway Contest" with a Generous Donation to Baby2Baby - PRNewsWire